fluzoparil
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2020 (NCT04552977)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Poly [ADP-ribose] polymerase 10INHIBITOR
PARP10 inhibitor
- Poly [ADP-ribose] polymerase 2INHIBITOR
PARP2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04933175 | Phase 2 | Jun 30, 2021 | Fujian Medical University, Fujian Provincial Hospital |
| NCT04552977 | Phase 2 | Sep 30, 2020 | Shandong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fujian Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Fujian Provincial Hospital | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Shandong University | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1